反応式
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[CH:12]=[CH:11][C:10]([O:13][CH2:14]/[CH:15]=[C:16](\I)/[CH3:17])=[N:9]2)=[CH:4][CH:3]=1.[CH3:19][O:20][C:21](=[O:24])[NH:22][CH3:23].P([O-])([O-])([O-])=O.[K+].[K+].[K+].CNCCNC>C1(C)C=CC=CC=1.[Cu](I)I>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[CH:12]=[CH:11][C:10]([O:13][CH2:14]/[CH:15]=[C:16](\[N:22]([CH3:23])[C:21](=[O:24])[O:20][CH3:19])/[CH3:17])=[N:9]2)=[CH:4][CH:3]=1参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
1.50 g (4.00 mmol) 1-(4-chlorophenyl)-3-[(Z)-3-iodobut-2-enoxy]pyrazole, 0.43 g (4.81 mmol) N-methylcarbamic acid methyl ester (9), 76 mg (0.4 mmol) copperiodide, 1.27 g (6.00 mmol) potassium phosphate and 71 mg (0.80 mmol) N,N′-dimethylethylene diamine in 14 ml toluene have been stirred for 1.5 d at 100° C. After removal of the solvents in vacuo the crude product has been purified by chromatography on 50 g silica with MTBE/hexane (1:3). Yield 0.67 g. 1H-NMR (CDCl3): δ=1.90 (s); 3.05 (s); 3.70 (s); 4.68 (m); 5.63 (m); 5.90 (d); 7.35 (m); 7.55 (m); 7.68 (d).
後処理
- customAfter removal of the solvents in vacuo the crude product
- customhas been purified by chromatography on 50 g silica with MTBE/hexane (1:3)
出典と根拠
- ORDレコード
- ord-a51a2316363c48bf8c622d7276414bee
- 出典データセット
- uspto-grants-2016_03
- 特許番号
- US09271501B2
関連ノート
読み込み中…